7 results
IDSA Recommended antimicrobial regimens for treatment of patients with Lyme disease.

#Management #InfectiousDiseases #Antibiotics #LymeDisease #Treatment #Regimens
IDSA Recommended ... antimicrobial regimens ... for treatment of ... InfectiousDiseases #Antibiotics ... #Regimens #IDSA
Parenteral Antimicrobial Treatment of Common Microorganisms Causing Native Vertebral Osteomyelitis - IDSA 
Staphylococci, oxacillin susceptible
Staphylococci, oxacillin
Parenteral Antimicrobial ... Treatment of Common ... Parenteral #IV #Antibiotics ... #pharmacology # ... idsa
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Outpatient Treatment ... fluoroquinolone #IDSA ... Acquired #Pneumonia #Antibiotics ... #Treatment #Regimen ... Management #Guidelines #pharmacology
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Potential Treatment ... infection Episode #Pharmacology ... CDifficile #IDSA2017 #Adjunct ... #Antibiotics
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Individualized Treatment ... #antimicrobials ... #regimens #pharmacology ... #dosing #idsa #
IDSA Summary of recommendations on drugs for use in a treatment regimen for patients with
multidrug-resistant tuberculosis,
IDSA Summary of ... regimen for patients ... #antimicrobials ... #pharmacology # ... ebm #idsa
Antimicrobial Regimens for Acute Bacterial Rhinosinusitis in Adults
Initial empirical therapy: 
 • Amoxicillin-clavulanate (500 mg/125 mg
Antimicrobial Regimens ... qd) Risk for antibiotic ... #empiric #idsa ... #antibiotics #Bacterial ... Adults #management #pharmacology